Microwave Ablation for Pulmonary Metastases From Colorectal Cancer

Soochow University

Status

Completed

Conditions

Colorectal Cancer

Treatments

Device: microwave ablation

Study type

Interventional

Funder types

Other

Identifiers

NCT02502630

CRC-MW-001

Details and patient eligibility

About

(MWA) is the most recent development in the field of local ablative therapies. The aim of this study was to evaluate CT-guided percutaneous microwave (MW) ablation safety and efficacy in pulmonary metastases from colorectal cancer.

Full description

From June 2010 to June 2015, 48 unresectable lesions in 32 patients with pulmonary metastases from colorectal cancer were selected for CT-guided microwave ablation. Patients were scheduled for a 1 and 3 month CT follow-up to evaluate lesion diameter.We retrospectively evaluated CT-guided percutaneous microwave (MW) ablation safety and efficacy in pulmonary metastases from colorectal cancer.

Enrollment

32 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Unresectable pulmonary metastases from colorectal cancer.
diagnosis by CT, and confirmed by percutaneous puncture biopsy.
Age range 18-70 years old.
Eastern Cooperative Oncology Group performance status 0-1.
Life expectancy of more than 3 months.
Adequate organ function.

Exclusion criteria

Resectable lung metastases.
Life expectancy less than 3 months
Patients with cardiac pacemaker, cerebral aneurysm clips, implanted electronic instruments or other metal materials.
Coagulopathy with platelet count less than 50000.
Active infectious disease.
Age below 18 years.
Pregnancy of breastfeeding.